RTP biotech Incyclix adds another $3M in funding
Incyclix, an emerging biotech focusing on the fight against cancer, has secured nearly $3 million in a $30 million round announced in 2022. In an SEC filing, the company, whose fou…
More from North Carolina Business
Business North Carolina Magazine
Systel founder Keith Allison steps into chairman role as daughters lead company
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
Krispy Kreme posts $19M loss as restructuring follows McDonald's breakup
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
Gov. Stein touts N.C.'s biotech, EV strength after Asia trade trip
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
FEMA sends $155M for Helene recovery, projects in western N.C.
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
New N.C. program helps small businesses offer health insurance
North Carolina Business
•
Nov 7, 2025
Business North Carolina Magazine
Trump-backed $80B Westinghouse plan could lead to U.S. stake, IPO
North Carolina Business
•
Nov 7, 2025
Business North Carolina Magazine
Nvidia CEO predicts China will surpass U.S. in AI race
North Carolina Business
•
Nov 6, 2025
Business North Carolina Magazine
N.C. insurers propose 68% hike in dwelling policy rates
North Carolina Business
•
Nov 6, 2025